rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    IGC
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      IGC Pharma earnings matched, revenue topped estimates
      Nov 10Investing.comIGC
      IGC Pharma Reports Third Quarter 2026 Financial Results and Provides Business Update
      Nov 9Yahoo FinanceIGC
      IGC Pharma's Alzheimer's Agitation Drug Candidate Now Patented in the U.S., Canada, and Mexico as Phase 2 Readout Nears
      Nov 5Yahoo FinanceIGC
      IGC Pharma Unveils PRISM AI Platform to Move Alzheimer's Risk Prediction to Brain-Health Action and Commercial Deployment

      POTOMAC, MD/ ACCESS Newswire/ October 13, 2026/ IGC Pharma, Inc., a clinical-stage biotechnology company advancing Alzheimer's disease therapeutics and Artificial Intelligence- enabled healthcare technologies, today announced the introduction of PRISM, a new application layer designed to bring its patent-pending MINT-AD Alzheimer's AI platform closer...

      Oct 13NasdaqIGC
      IGC Pharma Completes Enrollment in Phase 2 CALMA Alzheimer's Trial; Topline Results Expected Q4 2026
      Sep 28Yahoo FinanceIGC

      This is the newest page. Registered accounts read further back.